Skip to content

Effect of Strawberries on Cardiovascular Disease Risk

Effects of a Freeze Dried Strawberry Powder on Postprandial Vascular Function and Blood Markers of Cardiovascular Risk

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01989637
Enrollment
34
Registered
2013-11-21
Start date
2013-07-31
Completion date
2014-06-30
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease

Brief summary

It is important to identify and evaluate foods, such as strawberries, that can improve established and emerging cardiovascular risk factors, such as postprandial lipid and glycemic responses, and vascular health. Postprandial derangements may affect multiple metabolic pathways that lead to increased arterial stiffness. Research has demonstrated the potential of strawberries to ameliorate postprandial responses to a high fat/high glucose meal. Further research is needed to demonstrate this effect in better controlled clinical studies and explore whether metabolic effects lead to improved arterial health. The investigators propose to examine the effects of adding 40 g of freeze-dried strawberry powder to a high fat/high glucose meal on postprandial cardiovascular risk factor including lipids, insulin, glucose, and arterial stiffness and central blood pressure. The investigators hypothesize that the bioactive components of strawberry powder will attenuate postprandial lipemic and glycemic responses, as well as improve measures of arterial health.

Interventions

DIETARY_SUPPLEMENTStrawberry Meal

High-fat meal (50 g total fat) with 40 g freeze dried strawberry powder

DIETARY_SUPPLEMENTControl Meal

High-fat meal (50 g total fat) with a matched placebo powder containing no strawberry bioactives

Sponsors

California Strawberry Commission
CollaboratorOTHER
Penn State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 20-50 years of age * LDL-C below 160 mg/dL * Triglycerides below 350 mg/dL * No stage II hypertension (BP below 160/100 mmHg) * Not taking medication for elevated lipids, blood pressure, or glucose

Exclusion criteria

* Allergies to strawberries * Known intolerance to high fat meals * History of cardiovascular disease, kidney disease, diabetes or inflammatory diseases such as GI disorders and arthritis * Use of non-steroidal anti-inflammatory or immunosuppressant drugs * Conditions requiring the use of steroids * Use of medication or supplements for elevated lipids, blood pressure or glucose

Design outcomes

Primary

MeasureTime frame
Change from baseline in postprandial central blood pressure and arterial stiffness2 and 4 hours

Secondary

MeasureTime frame
Postprandial changes in insulin0, 0.5, 1, 2, and 4 hours
Postprandial changes in glucose0, 0.5, 1, 2, and 4 hours
Postprandial changes in markers of inflammation/oxidative stress0, 0.5, 1, 2, and 4 hours
Change from baseline in postprandial triglycerides at 0.5, 1, 2, and 4 hours0.5, 1, 2, and 4 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026